1ST DETECT SECURES SIGNIFICANT PURCHASE ORDER FOR ADDITIONAL CHECKPOINT SECURITY UNITS
November 13 2023 - 8:00AM
Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st
Detect subsidiary has accepted another significant purchase order
for seven of its TRACER 1000™ explosives trace detectors (ETDs),
for an airport security checkpoint. The systems will be deployed in
a European airport in Romania.
“We’re excited to begin Fiscal Year 2024 with
increased sales and interest in the TRACER 1000 from the security
checkpoint field. Based on the near-zero false alarm rate that mass
spectrometry provides, we believe that the TRACER 1000 improves
checkpoint efficiency and passenger throughput by reducing the need
for time-consuming pat-downs,” said Thomas B. Pickens III,
Chairman and Chief Executive Officer of 1st Detect.
The Astrotech Mass Spectrometer Technology™ (AMS
Technology) drives the breakthrough TRACER 1000, the first
certified ETD to employ mass spectrometry. Recognized as the gold
standard in chemical detection, mass spectrometry has historically
been too costly, bulky, and cumbersome to be used outside of the
laboratory. Unlike other technologies, the AMS Technology works
under ultra-high vacuum, which eliminates competing molecules that
can impair the accuracy and quality of an analysis. The TRACER 1000
is inexpensive, small, and easy to use, with high resolution and
near-zero false alarms. Due to its high sensitivity and rugged
design, the TRACER 1000 is the only mass spectrometry-based ETD to
have received European Civil Aviation Conference (ECAC)
certification for both checkpoint and cargo security.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry
company that launches, manages, and commercializes scalable
companies based on its innovative core technology through its
wholly owned subsidiaries. 1st
Detect develops, manufactures, and sells trace
detectors for use in the security and detection market.
AgLAB is developing chemical analyzers for use in
the agriculture market. BreathTech is developing a
breath analysis tool to screen for volatile organic compound
metabolites that could indicate they may have a bacterial or viral
infection. Astrotech is headquartered in Austin, Texas. For
information, please visit www.astrotechcorp.com.
Forward-Looking Statements
This press release contains forward-looking
statements that are made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are subject to risks, trends, and
uncertainties that could cause actual results to be materially
different from the forward-looking statement. These factors
include, but are not limited to, the adverse impact of inflationary
pressures, including significant increases in fuel costs, global
economic conditions and events related to these conditions,
including the ongoing wars in Ukraine and the middle east and the
COVID-19 pandemic, the Company’s use of proceeds from the common
stock offerings, whether we can successfully complete the
development of our new products and proprietary technologies,
whether we can obtain the FDA and other regulatory approvals
required to market our products under development in the United
States or abroad, whether the market will accept our products and
services and whether we are successful in identifying, completing
and integrating acquisitions, as well as other risk factors and
business considerations described in the Company’s Securities and
Exchange Commission filings including the Company’s most recent
Annual Report on Form 10-K. Any forward-looking statements in this
document should be evaluated in light of these important risk
factors. While we do not intend to directly harvest, manufacture,
distribute or sell cannabis or cannabis products, we may be
detrimentally affected by a change in enforcement by federal or
state governments and we may be subject to additional risks in
connection with the evolving regulatory area and associated
uncertainties. Any such effects may give rise to risks and
uncertainties that are currently unknown or amplify others
mentioned herein. Although the Company believes the expectations
reflected in its forward-looking statements are reasonable and are
based on reasonable assumptions, no assurance can be given that
these assumptions are accurate or that any of these expectations
will be achieved (in full or at all) or will prove to have been
correct. Moreover, such statements are subject to a number of
assumptions, risks and uncertainties, many of which are beyond the
control of the Company, which may cause actual results to differ
materially from those implied or expressed by the forward-looking
statements. In addition, any forward-looking statements included in
this press release represent the Company’s views only as of the
date of its publication and should not be relied upon as
representing its views as of any subsequent date. The Company
assumes no obligation to correct or update these forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by applicable law.
Company Contact: Jaime Hinojosa, Chief Financial Officer, Astrotech Corporation, (512) 485-9530
Astrotech (NASDAQ:ASTC)
Historical Stock Chart
From Jan 2025 to Feb 2025
Astrotech (NASDAQ:ASTC)
Historical Stock Chart
From Feb 2024 to Feb 2025